Structured evidence table for Panax Ginseng Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Panax Ginseng Cognition Randomized Trial | Methods We performed a systematic review and meta-analysis to quantitatively synthesize randomized controlled trial evidence on the efficacy of phytotherapeutic interventions for cancer-related fatigue and to assess the certainty of evidence. | 1 | Matsas S (2026) | Efficacy of Phytotherapy for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Panax Ginseng Cognition Randomized Trial | We also evaluated risk of bias (RoB 2), publication bias, and certainty of evidence using GRADE. | 1 | Matsas S (2026) | Efficacy of Phytotherapy for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Panax Ginseng Cognition Randomized Trial | Most trials had high or unclear risk of bias, and the certainty of evidence was rated very low. | 1 | Matsas S (2026) | Efficacy of Phytotherapy for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Panax Ginseng Cognition Randomized Trial | Background Cancer-related fatigue (CRF) is one of the most common and burdensome symptoms faced by patients with cancer, yet effective drug-based treatments remain limited. | 1 | Matsas S (2026) | Efficacy of Phytotherapy for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Panax Ginseng Cognition Randomized Trial | Ginsenosides are the prime pharmacologically active compounds responsible for the medicinal properties of ginseng, which are also found in many otherspecies, includingand. | 3 | Cortés Hernán (2026) | Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine |
| Panax Ginseng Cognition Randomized Trial | Some studies have reported reduced plasma concentrations of warfarin and enhanced aspirin bioavailability after ginseng intake, indicating possible pharmacokinetic and pharmacodynamic interactions. | 3 | Cortés Hernán (2026) | Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine |
| Panax Ginseng Cognition Randomized Trial | Alzheimer's disease (AD) is a result of a neurodegenerative process, which is associated with beta‐amyloid deposition and neurofibrillary tangles formation (Wang et al. ). | 3 | Cortés Hernán (2026) | Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine |
| Panax Ginseng Cognition Randomized Trial | AD Akt AMP AMPK APP/Aβ AUC BBB [Ca] CaN CaSR Cl C CNS CYP CYP‐7A DMT1 DMT2 EMT FoxO1 FSH G6Pase GLUT4 GRg1 GSK‐3β Haspin HD HO‐1 HSC IC IL‐1β LDL LH LPS MAPKs MPTP mRNA MRT NF‐κB nNOS NO OGD PC12 PD PDGF PEPCK PINK PPARγ PPD SAMP8 SMAD Smad7 SNpc SREBP‐1C T TGF‐β1 TLR T TNF‐α V VEGF Panax ginseng P. | 3 | Cortés Hernán (2026) | Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine |
Source documents